Fennec Pharmaceuticals Inc (FENC) Ownership

$9.08

$0.4 (4.61%)
Last update: 01:13 PM EST
Day's range
$8.68
Day's range
$9.19

Fennec Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ROSALIND ADVISORS, INC. 02/12/2026 2.61 M $20.12 M   25.84% 9.37%
AIGH CAPITAL MANAGEMENT LLC 02/02/2026 1.58 M $12.18 M   132.06% 5.67%
BLACKROCK, INC. 02/12/2026 1.23 M $9.50 B   1.85% 4.43%
VANGUARD GROUP INC 01/29/2026 1.07 M $8.22 M   11.71% 3.83%
AWM INVESTMENT COMPANY, INC. 02/13/2026 711.87 K $5.48 M   100.00% 2.55%
STATE STREET CORP 02/13/2026 352.78 K $2.72 M   3.39% 1.26%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 297.10 K $2.29 M   -1.22% 1.07%
MORGAN STANLEY 02/13/2026 242.48 K $1.87 M   4.33% 0.87%
CITADEL ADVISORS LLC 02/17/2026 199.75 K $1.54 M   85.82% 0.72%
GENDELL JEFFREY L 02/13/2026 139.56 K $1.07 M   0.00% 0.50%
MARSHALL WACE, LLP 02/13/2026 127.69 K $983.24 K   100.00% 0.46%
POTOMAC CAPITAL MANAGEMENT, INC. 02/11/2026 95.10 K $732.27 M   100.00% 0.34%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 57.25 K $440.82 K   0.00% 0.21%
HARTFORD FINANCIAL MANAGEMENT INC. 01/21/2026 50.65 K $389.98 K   0.00% 0.18%
STONEPINE CAPITAL MANAGEMENT, LLC 02/13/2026 50.00 K $385.00 K   100.00% 0.18%
BANK OF NEW YORK MELLON CORP 02/10/2026 49.22 K $378.99 K   -5.85% 0.18%
HILLSDALE INVESTMENT MANAGEMENT INC. 02/10/2026 44.00 K $338.80 K   100.00% 0.16%
GOLDMAN SACHS GROUP INC 02/10/2026 43.59 K $335.64 K   64.55% 0.16%
BARCLAYS PLC 02/13/2026 36.60 K $281.80 K   10.77% 0.13%
RHUMBLINE ADVISERS 02/13/2026 29.04 K $223.59 K   -13.38% 0.10%
1492 CAPITAL MANAGEMENT LLC 02/10/2026 28.09 K $216.31 K   100.00% 0.10%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 27.06 K $207.00 K   152.70% 0.10%
XTX TOPCO LTD 02/17/2026 26.79 K $206.25 M   26.07% 0.10%
WELLS FARGO & COMPANY/MN 02/13/2026 26.16 K $201.42 K   53.74% 0.09%
NUVEEN, LLC 02/12/2026 26.01 K $200.25 M   0.00% 0.09%
JONES FINANCIAL COMPANIES LLLP 02/17/2026 24.95 K $192.13 K   165.45% 0.09%
JANE STREET GROUP, LLC 02/12/2026 24.04 K $185.14 M   -66.90% 0.09%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 20.00 K $154.00 K   88.68% 0.07%
DEUTSCHE BANK AG\ 02/11/2026 17.37 K $133.71 K   100.00% 0.06%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 15.14 K $116.57 K   0.85% 0.05%
HIGHTOWER ADVISORS, LLC 02/06/2026 15.00 K $115.50 K   0.00% 0.05%
SQUAREPOINT OPS LLC 02/13/2026 13.11 K $100.94 K   100.00% 0.05%
METLIFE INVESTMENT MANAGEMENT, LLC 02/12/2026 13.02 K $100.25 K   35.71% 0.05%
TWO SIGMA ADVISERS, LP 02/17/2026 13.00 K $100.10 K   100.00% 0.05%
INTECH INVESTMENT MANAGEMENT LLC 02/10/2026 10.45 K $80.48 K   -8.19% 0.04%
JPMORGAN CHASE & CO 02/11/2026 9.77 K $75.24 K   -0.56% 0.04%
NEW YORK STATE COMMON RETIREMENT FUND 02/12/2026 9.75 K $75.10 K   0.00% 0.04%
LEGAL & GENERAL GROUP PLC 02/09/2026 8.13 K $62.78 K   0.00% 0.03%
POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY 02/13/2026 6.25 K $48.13 K   0.00% 0.02%
STRS OHIO 02/02/2026 5.20 K $40.04 K   0.00% 0.02%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 5.05 K $38.89 K   12.05% 0.02%
UBS GROUP AG 01/29/2026 5.00 K $38.46 M   -63.57% 0.02%
FEDERATED HERMES, INC. 02/12/2026 2.92 K $22.45 K   0.00% 0.01%
ROYAL BANK OF CANADA 02/17/2026 2.47 K $19.00 K   122.05% 0.01%
STATE OF ALASKA, DEPARTMENT OF REVENUE 01/23/2026 1.57 K $12.00 K   100.00% 0.01%
CIBC PRIVATE WEALTH GROUP, LLC 02/12/2026 1.57 K $12.05 K   0.00% 0.01%
AMERITAS INVESTMENT PARTNERS, INC. 02/11/2026 1.50 K $11.54 K   0.00% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 02/17/2026 1.38 K $10.66 M   -14.78% 0.01%
STERLING CAPITAL MANAGEMENT LLC 02/13/2026 1.03 K $7.93 K   -14.02% 0.00%
CWM, LLC 01/26/2026 750 $6.00 K   -7.52% 0.00%

Fennec Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 87 institutional investors and hedge funds held shares of Fennec Pharmaceuticals Inc. The most heavily invested institutionals were:

Rosalind Advisors, Inc.: 2.61 M

AIGH Capital Management LLC: 1.58 M

BlackRock, Inc.: 1.23 M

VANGUARD GROUP INC: 1.07 M

AWM Investment Company, Inc.: 711,869

STATE STREET CORP: 352,775

26.00% of Fennec Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 16.14 M shares in the last 24 months. This purchase volume represents approximately $146.58 M in transactions.